Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Urinary Tract Infections 1 Staphylococcal Infections 1 Spasm 1 Sleep Initiation and Maintenance Disorders 1 Sepsis 1 Seizures 1 Schizophrenia, Treatment-Resistant 1 Schizophrenia 1 Retinitis 1 Renal Insufficiency, Chronic 1 Pulmonary Arterial Hypertension 1 Pneumonia 1 Pain 1 Neutropenia 1 Migraine Disorders 1 Menorrhagia 1 Meningitis, Bacterial 1 Meningitis 1 Lymphoma 1 Leukemia 1 Intraabdominal Infections 1 Influenza, Human 1 Inflammation 1 Infections 1 Hypokalemia 1 Hypertension 1 Hyperaldosteronism 1 Herpes Simplex 1 Hemophilia A 1 Hemangioma, Capillary 1

Interventions

Cyclophosphamide 297 Rituximab 272 Etoposide 149 Filgrastim 142 fludarabine phosphate 120 Cytarabine 109 Vincristine 107 Melphalan 102 Radiotherapy 101 Doxorubicin 97 Peripheral Blood Stem Cell Transplantation 93 Methotrexate 91 fludarabine 86 Prednisone 86 Busulfan 86 Tacrolimus 66 Mycophenolic Acid 62 Granulocyte Colony-Stimulating Factor 60 Antilymphocyte Serum 58 Dexamethasone 57 Whole-Body Irradiation 55 Carmustine 54 Bortezomib 45 Cyclosporine 44 Lenalidomide 41 Methylprednisolone 40 sargramostim 39 Bendamustine Hydrochloride 37 ibritumomab tiuxetan 34 Ifosfamide 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma × Clozapine × Clear all

NCT04074213 2019-08-30

CLOZARIX

University Hospital, Caen

1,000,000 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡